15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
2-(3-Methoxyphenyl)quinazoline Derivatives: A New Class of Direct Constitutive Androstane Receptor (CAR) Agonists.

Palacky University In Olomouc
Development of CINPA1 analogs as novel and potent inverse agonists of constitutive androstane receptor.

St. Jude Children'S Research Hospital
Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORß and ROR¿t.

Phenex Pharmaceuticals
Molecular determinants of steroid inhibition for the mouse constitutive androstane receptor.

University of Kuopio
Synthesis and pharmacological validation of a novel series of non-steroidal FXR agonists.

Phenex Pharmaceuticals
Structure-Based Design and Optimization Lead to the Identification of a Novel Potent sEH Inhibitor with PPARγ Partial Agonist Activity against Inflammatory and Metabolic-Related Diseases.

Shenyang Pharmaceutical University
Potent and Selective Human Constitutive Androstane Receptor Activator DL5055 Facilitates Cyclophosphamide-Based Chemotherapies.

University of Maryland
Development of BODIPY FL SNS 032 as a Versatile Probe for Constitutive Androstane Receptor and Multiple Kinases.

St. Jude Children's Research Hospital
2-Substituted quinazolines: Partial agonistic and antagonistic ligands of the constitutive androstane receptor (CAR).

Charles University
Discovery of Novel Human Constitutive Androstane Receptor Agonists with the Imidazo[1,2-

Czech Academy of Sciences
GNE-235: A Lead Compound Selective for the Second Bromodomain of PBRM1.

Genentech
Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders.

Tes Pharma
Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation.

Goethe University Frankfurt
DL5050, a Selective Agonist for the Human Constitutive Androstane Receptor.

University of Maryland
Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies.

University of Maryland